Total Payments
$299.87
2024 Payments
$15.41
Companies
11
Transactions
20
Medicare Patients
1,878
Medicare Billing
$581,212
Payment Breakdown by Category
Food & Beverage$299.87 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $299.87 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $87.57 | 6 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $41.14 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $33.53 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $29.08 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17.16 | 1 | $0 (2023) |
| Amgen Inc. | $16.73 | 1 | $0 (2023) |
| Neurelis, Inc. | $15.98 | 1 | $0 (2022) |
| Evoke Pharma, Inc. | $15.18 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.73 | 1 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $14.59 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.41 | 1 | GlaxoSmithKline, LLC. ($15.41) |
| 2023 | $68.23 | 4 | Janssen Pharmaceuticals, Inc ($17.68) |
| 2022 | $216.23 | 15 | Lilly USA, LLC ($70.91) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Inflammation | ||||||
| 04/27/2023 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/14/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Central Nervous System | ||||||
| 12/14/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.68 | General |
| Category: Cardiovascular | ||||||
| 11/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Gastroenterology | ||||||
| 10/12/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: Cardiovascular | ||||||
| 08/30/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: EPILEPSY | ||||||
| 06/27/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Neuroscience | ||||||
| 06/21/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiovascular | ||||||
| 06/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Gastroenterology | ||||||
| 05/09/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/23/2022 | Lilly USA, LLC | BAQSIMI (Drug), TRULICITY | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes | ||||||
| 01/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,502 | 7,845 | $1.8M | $496,378 |
| 2022 | 7 | 376 | 1,288 | $555,983 | $84,834 |
Total Patients
1,878
Total Services
9,133
Medicare Billing
$581,212
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 354 | 2,966 | $996,100 | $227,773 | 22.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 367 | 2,284 | $329,940 | $124,629 | 37.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 138 | 718 | $79,413 | $39,253 | 49.4% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 12 | 273 | $68,250 | $25,277 | 37.0% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 212 | 584 | $46,720 | $16,942 | 36.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 105 | 116 | $70,918 | $15,116 | 21.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 264 | $39,600 | $14,546 | 36.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 100 | 330 | $23,110 | $9,519 | 41.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 127 | $46,228 | $7,301 | 15.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 70 | $36,750 | $6,052 | 16.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 31 | 31 | $6,458 | $2,874 | 44.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $11,000 | $2,772 | 25.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 21 | 21 | $3,230 | $2,046 | 63.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 17 | $8,918 | $1,366 | 15.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 17 | 22 | $4,180 | $911.62 | 21.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 179 | 963 | $441,054 | $63,918 | 14.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 78 | 127 | $15,875 | $6,417 | 40.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 50 | 50 | $41,900 | $5,989 | 14.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 95 | $34,741 | $4,903 | 14.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 23 | $12,075 | $1,705 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $9,738 | $1,684 | 17.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 12 | 12 | $600.00 | $219.00 | 36.5% |
About Andre Augustin, APN
Andre Augustin, APN is a Nursing Care healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2022. The National Provider Identifier (NPI) number assigned to this provider is 1376291013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andre Augustin, APN has received a total of $299.87 in payments from pharmaceutical and medical device companies, with $15.41 received in 2024. These payments were reported across 20 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($299.87).
As a Medicare-enrolled provider, Augustin has provided services to 1,878 Medicare beneficiaries, totaling 9,133 services with total Medicare billing of $581,212. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nursing Care
- Other Specialties Gerontology
- Location Bloomfield, NJ
- Active Since 03/11/2022
- Last Updated 04/07/2022
- Taxonomy Code 251J00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376291013
Products in Payments
- BAQSIMI (Drug) $56.22
- Livalo (Drug) $41.14
- XARELTO (Drug) $33.53
- TRELEGY ELLIPTA (Drug) $29.08
- AUSTEDO (Drug) $17.16
- Otezla (Drug) $16.73
- TRULICITY (Drug) $16.66
- VALTOCO (Drug) $15.98
- GIMOTI (Drug) $15.18
- XIFAXAN (Drug) $14.73
- EMGALITY (Drug) $14.69
- Kerendia (Drug) $14.59
- AFREZZA (Drug) $14.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.